Eko's smart stethoscopes have been used by U.S. physicians to automatically detect signs of atrial fibrillation and heart murmurs since its first FDA clearance arrived in 2020. A new regulatory OK unveiled this week aims to make the devices even smarter.
The company's latest clearance covers its artificial intelligence-powered Eko Murmur Analysis Software, or EMAS, which doesn't just detect heart murmurs, but also identifies their timing and severity. The software was given the green light to help diagnose murmurs in patients of all ages-an upgrade from the digital stethoscope's original software platform, which was cleared only for adult patients.
Read more at Fierce Biotech
Please note: Murmur detection is part of Eko’s SENSORA™ Cardiac Disease Detection Platform. Contact our sales team to learn more.